"The more booster doses you get, the less your body respond to them," Cottrell tells Health Ranger Mike Adams during the program "Health Ranger Report" on Brighteon.TV.
Cottrell demonstrates on a white board the decreasing number of antibodies induced by booster doses. He shows that the immunoglobulin G (IgG) will initially shot up following a second dose, but the succeeding booster doses will produce lower and lower peaks. The immunoglobulin M (IgM) will have moderate spike after the second dose, but will similarly trend downward in succeeding booster doses.
"Your immune system slowly becomes less reactive to the vaccines. The more booster shots you take will guarantee that your IgM and IgG are going to be less responsive, and it will lead to more escaped variants."
IgG is the most common type of antibody in your blood and other body fluids. When you have natural immunity, these antibodies protect you against infection by remembering the germs you've been exposed to before.
Meanwhile, your body makes IgM antibodies when you are first infected with new bacteria or other germs. They are your body's first line of defense against infections. When your body senses an invader, your IgM level will increase for a short time. It will then begin to drop as your IgG level kicks in and increases to protect you long-term.
Adams points out that what's happening in Israel right now is a perfect example of the waning effectiveness of COVID-19 vaccines.
"[More than] 80 percent vaccine uptake rate among adults there, but now record high cases, hospitalizations and so on among the fully vaccinated for the most part," says Adams. (Related: VACCINE FAIL: One in three new covid cases in Los Angeles are "breakthroughs" among fully vaccinated.)
Approximately 2.35 million Israelis have also received booster doses, and Adams says Israeli officials recently announced that they will roll out a fourth booster shot and will probably have more for every five to six months going forward.
The record high cases that Adams talks about pertain to the new data from the University of Oxford, which shows that Israel has the highest number of COVID-19 cases per capita.
Israel's rolling seven-day average of 1,143 COVID-19 cases per million people on Sept. 3 more than doubled the 501 per million reported in the U.S. on the same period.
The Jerusalem Post recently reported that since the beginning of August, nearly 200,000 Israelis have tested positive for COVID-19 and 564 people have died with a COVID-19 diagnosis. In early August, Israel's Ministry of Health reported that 64 percent of the country's 400 COVID-19 patients in serious condition were fully vaccinated.
Apparently, the Israelis are ignoring the data from their own studies.
Israel's preliminary vaccine data published in July found that Pfizer's COVID-19 vaccine was just 40.5 percent effective on average at preventing symptomatic infections.
The analysis, which was carried out as the delta variant became the dominant strain in the country, appeared to show a waning effectiveness of the Pfizer vaccine. It was only 16 percent effective against symptomatic infections for those who had two doses back in January. For people that had received two doses by April, the efficacy rate against symptomatic infection stood at 79 percent.
Researchers from another Israeli study have found that people who get COVID-19 vaccine are more likely to catch the disease than those who have recovered from a previous infection.
People given two doses of Pfizer's COVID-19 vaccine are almost six times more likely to contract a delta infection and seven times more likely to have symptomatic disease than those who recovered.
"This analysis demonstrated that natural immunity affords longer lasting and stronger protection against infection, symptomatic disease and hospitalization due to the delta variant," the researchers say.
The analysis has also shown that protection from an earlier infection wanes with time. The risk of a vaccine-breakthrough delta case is 13 times higher than the risk of developing a second infection when the original illness occurred during January or February this year.
Dr. Michael Segal, a neurologist and neuroscientist, has explained why people vaccinated against COVID-19 are still contracting and spreading the disease at a high rate.
Segal says the vaccines only stimulate internal immunity but do nothing to address mucosal immunity. Internal immunity protects the inside of the body while mucosal immunity provides the first line of defense by protecting the nose and mouth, and by doing so also reduces spread to others.
He said that all COVID-19 vaccines "are largely ineffective at stimulating the secretion of a particular form of antibodies called Immunoglobulin A (IgA) into our noses that occurs after actual infection with a virus."
Meanwhile, those who have contracted and recovered from the disease have both mucosal and internal immunity. (Related: COVID-19 natural immunity vs vaccine-induced immunity guide.)
That's the reason why some experts are now recommending that the virus be allowed to circulate throughout the population, with precautions taken for vulnerable individuals.
"We really cannot do anything else but allow the virus to take its course in order for the population to achieve herd immunity," says Porolfur Gudnason, chief epidemiologist of Iceland's Directorate of Health. "We need to try to vaccinate and better protect those who are vulnerable but let us tolerate the infection. It is not a priority now to vaccinate everyone with the third dose."
Eleanor Riley, an immunologist from the University of Edinburgh, also bats against booster shots.
"If you had a real humdinger of an infection, you may have better immunity to any new variants that pop up as you have immunity to more than just spike [protein]," says Riley. "We could be digging ourselves into a hole, for a very long time, where we think we can only keep COVID away by boosting every year."
Watch the Sept. 15 episode of the "Health Ranger Report" with Health Ranger Mike Adams here:
You can catch the "Health Ranger Report" live from Monday to Friday at 3-3:30 p.m. on Brighteon.TV.
Follow Immunization.news for more news and information related to coronavirus vaccines.